Loading…
Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys
The therapeutic application of growth factors to human disease has become closer to reality with the advent of faster means of synthesizing these molecules and novel drug delivery strategies. Epidermal growth factor (EGF) belongs to a large family of molecules with the ability to modulate growth. Pu...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS 1996-05, Vol.93 (10), p.4957-4961 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c518t-34b0a955b46b0e1c16e590b5bd6c552195730017b05ea1258fab142cdc66190f3 |
---|---|
cites | |
container_end_page | 4961 |
container_issue | 10 |
container_start_page | 4957 |
container_title | Proceedings of the National Academy of Sciences - PNAS |
container_volume | 93 |
creator | Keiser, Joan A. Ryan, Michael J. |
description | The therapeutic application of growth factors to human disease has become closer to reality with the advent of faster means of synthesizing these molecules and novel drug delivery strategies. Epidermal growth factor (EGF) belongs to a large family of molecules with the ability to modulate growth. Purified extracts of EGF have been used clinically to modulate gastrointestinal secretion of hormones and accelerate healing. EGF is also reported to have both vascular smooth muscle contractile and relaxing activity. Cardiovascular studies were performed with the bioactive 48-amino acid fragment of human EGF in rodents and primates to determine the effects of EGF on blood pressure and heart rate in conscious animals. Intravenous infusion of EGF induced an initial pressor response in rats followed by a prolonged decrease in blood pressure. In contrast, in monkeys, EGF had dose-related blood pressure-lowering effects only; significant hypotension was observed at doses ranging from 3 to 300 μ g/kg i.v. Hypotension was associated with modest tachycardia in both species. To our knowledge, this is the first report of hemodynamic effects of EGF in primates, and it clearly documents that the mitogenic role of growth factors such as EGF is but one aspect of their physiology. |
doi_str_mv | 10.1073/pnas.93.10.4957 |
format | article |
fullrecord | <record><control><sourceid>jstor_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1073_pnas_93_10_4957</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>38884</jstor_id><sourcerecordid>38884</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-34b0a955b46b0e1c16e590b5bd6c552195730017b05ea1258fab142cdc66190f3</originalsourceid><addsrcrecordid>eNqFkcGL1DAUxoMo67h6FgSleNBTZ99rkjYBLzLM7gojgug5pGnqdmyTMWndnf_elBkH14OewuP7fY987yPkOcISoaIXO6fjUtI0LJnk1QOyQJCYl0zCQ7IAKKpcsII9Jk9i3AKA5ALOyJkoGeWIC7K5toNv9k4PncnWbWvNGDPfZutd19gw6D67Cv52vMkutRl9yDqXrbyLpvNTzD7rBGvXZB-9-2738Sl51Oo-2mfH95x8vVx_WV3nm09XH1bvN7nhKMacshq05LxmZQ0WDZaWS6h53ZSG8wJTDgqAVQ3caiy4aHWNrDCNKUuU0NJz8u6wdzfVg22MdWPQvdqFbtBhr7zu1H3FdTfqm_-pqKSiSvY3R3vwPyYbRzV00di-186mWKoSgFhQ-C-InEvOKkzg67_ArZ-CSzdQBWAhaMlFgi4OkAk-xmDb04cR1FymmstUks7zXGZyvPwz54k_tpf0V0d9Nv5W7y14-09AtVPfj_ZuTOSLA7mNqeYTSoUQjP4CQGy7SA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201283658</pqid></control><display><type>article</type><title>Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys</title><source>PubMed Central</source><source>JSTOR</source><creator>Keiser, Joan A. ; Ryan, Michael J.</creator><creatorcontrib>Keiser, Joan A. ; Ryan, Michael J.</creatorcontrib><description>The therapeutic application of growth factors to human disease has become closer to reality with the advent of faster means of synthesizing these molecules and novel drug delivery strategies. Epidermal growth factor (EGF) belongs to a large family of molecules with the ability to modulate growth. Purified extracts of EGF have been used clinically to modulate gastrointestinal secretion of hormones and accelerate healing. EGF is also reported to have both vascular smooth muscle contractile and relaxing activity. Cardiovascular studies were performed with the bioactive 48-amino acid fragment of human EGF in rodents and primates to determine the effects of EGF on blood pressure and heart rate in conscious animals. Intravenous infusion of EGF induced an initial pressor response in rats followed by a prolonged decrease in blood pressure. In contrast, in monkeys, EGF had dose-related blood pressure-lowering effects only; significant hypotension was observed at doses ranging from 3 to 300 μ g/kg i.v. Hypotension was associated with modest tachycardia in both species. To our knowledge, this is the first report of hemodynamic effects of EGF in primates, and it clearly documents that the mitogenic role of growth factors such as EGF is but one aspect of their physiology.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.93.10.4957</identifier><identifier>PMID: 8643511</identifier><language>eng</language><publisher>United States: National Academy of Sciences of the United States of America</publisher><subject>Animals ; Blood pressure ; Blood Pressure - drug effects ; Cardiovascular Agents - administration & dosage ; Cardiovascular Agents - pharmacology ; Dosage ; Dose-Response Relationship, Drug ; Epidermal Growth Factor - administration & dosage ; Epidermal Growth Factor - pharmacology ; Heart rate ; Heart Rate - drug effects ; Hemodynamics ; Hemodynamics - drug effects ; Hormones ; Human resources ; Humans ; Hypertension ; Infusions, Intravenous ; Macaca fascicularis ; Male ; Molecular biology ; Monkeys ; Monkeys & apes ; Peptide Fragments - administration & dosage ; Peptide Fragments - pharmacology ; Primates ; Rats ; Recombinant Proteins - administration & dosage ; Recombinant Proteins - pharmacology ; Rodents ; Species Specificity</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1996-05, Vol.93 (10), p.4957-4961</ispartof><rights>Copyright 1996 National Academy of Sciences</rights><rights>Copyright National Academy of Sciences May 14, 1996</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-34b0a955b46b0e1c16e590b5bd6c552195730017b05ea1258fab142cdc66190f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/93/10.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/38884$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/38884$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8643511$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Keiser, Joan A.</creatorcontrib><creatorcontrib>Ryan, Michael J.</creatorcontrib><title>Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>The therapeutic application of growth factors to human disease has become closer to reality with the advent of faster means of synthesizing these molecules and novel drug delivery strategies. Epidermal growth factor (EGF) belongs to a large family of molecules with the ability to modulate growth. Purified extracts of EGF have been used clinically to modulate gastrointestinal secretion of hormones and accelerate healing. EGF is also reported to have both vascular smooth muscle contractile and relaxing activity. Cardiovascular studies were performed with the bioactive 48-amino acid fragment of human EGF in rodents and primates to determine the effects of EGF on blood pressure and heart rate in conscious animals. Intravenous infusion of EGF induced an initial pressor response in rats followed by a prolonged decrease in blood pressure. In contrast, in monkeys, EGF had dose-related blood pressure-lowering effects only; significant hypotension was observed at doses ranging from 3 to 300 μ g/kg i.v. Hypotension was associated with modest tachycardia in both species. To our knowledge, this is the first report of hemodynamic effects of EGF in primates, and it clearly documents that the mitogenic role of growth factors such as EGF is but one aspect of their physiology.</description><subject>Animals</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiovascular Agents - administration & dosage</subject><subject>Cardiovascular Agents - pharmacology</subject><subject>Dosage</subject><subject>Dose-Response Relationship, Drug</subject><subject>Epidermal Growth Factor - administration & dosage</subject><subject>Epidermal Growth Factor - pharmacology</subject><subject>Heart rate</subject><subject>Heart Rate - drug effects</subject><subject>Hemodynamics</subject><subject>Hemodynamics - drug effects</subject><subject>Hormones</subject><subject>Human resources</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Infusions, Intravenous</subject><subject>Macaca fascicularis</subject><subject>Male</subject><subject>Molecular biology</subject><subject>Monkeys</subject><subject>Monkeys & apes</subject><subject>Peptide Fragments - administration & dosage</subject><subject>Peptide Fragments - pharmacology</subject><subject>Primates</subject><subject>Rats</subject><subject>Recombinant Proteins - administration & dosage</subject><subject>Recombinant Proteins - pharmacology</subject><subject>Rodents</subject><subject>Species Specificity</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqFkcGL1DAUxoMo67h6FgSleNBTZ99rkjYBLzLM7gojgug5pGnqdmyTMWndnf_elBkH14OewuP7fY987yPkOcISoaIXO6fjUtI0LJnk1QOyQJCYl0zCQ7IAKKpcsII9Jk9i3AKA5ALOyJkoGeWIC7K5toNv9k4PncnWbWvNGDPfZutd19gw6D67Cv52vMkutRl9yDqXrbyLpvNTzD7rBGvXZB-9-2738Sl51Oo-2mfH95x8vVx_WV3nm09XH1bvN7nhKMacshq05LxmZQ0WDZaWS6h53ZSG8wJTDgqAVQ3caiy4aHWNrDCNKUuU0NJz8u6wdzfVg22MdWPQvdqFbtBhr7zu1H3FdTfqm_-pqKSiSvY3R3vwPyYbRzV00di-186mWKoSgFhQ-C-InEvOKkzg67_ArZ-CSzdQBWAhaMlFgi4OkAk-xmDb04cR1FymmstUks7zXGZyvPwz54k_tpf0V0d9Nv5W7y14-09AtVPfj_ZuTOSLA7mNqeYTSoUQjP4CQGy7SA</recordid><startdate>19960514</startdate><enddate>19960514</enddate><creator>Keiser, Joan A.</creator><creator>Ryan, Michael J.</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><general>National Academy of Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19960514</creationdate><title>Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys</title><author>Keiser, Joan A. ; Ryan, Michael J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-34b0a955b46b0e1c16e590b5bd6c552195730017b05ea1258fab142cdc66190f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiovascular Agents - administration & dosage</topic><topic>Cardiovascular Agents - pharmacology</topic><topic>Dosage</topic><topic>Dose-Response Relationship, Drug</topic><topic>Epidermal Growth Factor - administration & dosage</topic><topic>Epidermal Growth Factor - pharmacology</topic><topic>Heart rate</topic><topic>Heart Rate - drug effects</topic><topic>Hemodynamics</topic><topic>Hemodynamics - drug effects</topic><topic>Hormones</topic><topic>Human resources</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Infusions, Intravenous</topic><topic>Macaca fascicularis</topic><topic>Male</topic><topic>Molecular biology</topic><topic>Monkeys</topic><topic>Monkeys & apes</topic><topic>Peptide Fragments - administration & dosage</topic><topic>Peptide Fragments - pharmacology</topic><topic>Primates</topic><topic>Rats</topic><topic>Recombinant Proteins - administration & dosage</topic><topic>Recombinant Proteins - pharmacology</topic><topic>Rodents</topic><topic>Species Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Keiser, Joan A.</creatorcontrib><creatorcontrib>Ryan, Michael J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Keiser, Joan A.</au><au>Ryan, Michael J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1996-05-14</date><risdate>1996</risdate><volume>93</volume><issue>10</issue><spage>4957</spage><epage>4961</epage><pages>4957-4961</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>The therapeutic application of growth factors to human disease has become closer to reality with the advent of faster means of synthesizing these molecules and novel drug delivery strategies. Epidermal growth factor (EGF) belongs to a large family of molecules with the ability to modulate growth. Purified extracts of EGF have been used clinically to modulate gastrointestinal secretion of hormones and accelerate healing. EGF is also reported to have both vascular smooth muscle contractile and relaxing activity. Cardiovascular studies were performed with the bioactive 48-amino acid fragment of human EGF in rodents and primates to determine the effects of EGF on blood pressure and heart rate in conscious animals. Intravenous infusion of EGF induced an initial pressor response in rats followed by a prolonged decrease in blood pressure. In contrast, in monkeys, EGF had dose-related blood pressure-lowering effects only; significant hypotension was observed at doses ranging from 3 to 300 μ g/kg i.v. Hypotension was associated with modest tachycardia in both species. To our knowledge, this is the first report of hemodynamic effects of EGF in primates, and it clearly documents that the mitogenic role of growth factors such as EGF is but one aspect of their physiology.</abstract><cop>United States</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>8643511</pmid><doi>10.1073/pnas.93.10.4957</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8424 |
ispartof | Proceedings of the National Academy of Sciences - PNAS, 1996-05, Vol.93 (10), p.4957-4961 |
issn | 0027-8424 1091-6490 |
language | eng |
recordid | cdi_crossref_primary_10_1073_pnas_93_10_4957 |
source | PubMed Central; JSTOR |
subjects | Animals Blood pressure Blood Pressure - drug effects Cardiovascular Agents - administration & dosage Cardiovascular Agents - pharmacology Dosage Dose-Response Relationship, Drug Epidermal Growth Factor - administration & dosage Epidermal Growth Factor - pharmacology Heart rate Heart Rate - drug effects Hemodynamics Hemodynamics - drug effects Hormones Human resources Humans Hypertension Infusions, Intravenous Macaca fascicularis Male Molecular biology Monkeys Monkeys & apes Peptide Fragments - administration & dosage Peptide Fragments - pharmacology Primates Rats Recombinant Proteins - administration & dosage Recombinant Proteins - pharmacology Rodents Species Specificity |
title | Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A30%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hemodynamic%20Effects%20of%20Epidermal%20Growth%20Factor%20in%20Conscious%20Rats%20and%20Monkeys&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Keiser,%20Joan%20A.&rft.date=1996-05-14&rft.volume=93&rft.issue=10&rft.spage=4957&rft.epage=4961&rft.pages=4957-4961&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.93.10.4957&rft_dat=%3Cjstor_cross%3E38884%3C/jstor_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c518t-34b0a955b46b0e1c16e590b5bd6c552195730017b05ea1258fab142cdc66190f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=201283658&rft_id=info:pmid/8643511&rft_jstor_id=38884&rfr_iscdi=true |